02 Feb 2007 - Interferon-beta is used for multiple sclerosis therapy. An interferon-beta protein developed at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart, Germany, in collaboration with CinnaGen company, Tehran, Iran, is now the first therapeutic protein from a Fraunhofer laboratory to be approved as biogeneric / biosimilar medicine.
I'm not sure what the global biogenerics landscape looks like but perhaps we can learn from other countries experiences if they're trying it ahead of us.
No comments:
Post a Comment